Filing Details
- Accession Number:
- 0001787306-25-000115
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-08-05 18:28:38
- Reporting Period:
- 2025-08-01
- Filing Date:
- 2025-08-05
- Accepted Time:
- 2025-08-05 18:28:38
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1787306 | Arcutis Biotherapeutics Inc. | ARQT | Pharmaceutical Preparations (2834) | 812974255 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1801050 | G. Howard Welgus | C/O Arcutis Biotherapeutics, Inc. 3027 Townsgate Road, Suite 300 Westlake Village CA 91361 | Yes | No | No | No |
Transaction Summary
| Sold: | 10,000 shares | Avg. Price: $14.30 | Total Value: $142,982.00 |
| Number of Shares After Transactions: | 100,206 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-08-01 | 6,110 | $0.00 | 106,316 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2025-08-01 | 6,110 | $14.30 | 100,206 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2025-08-01 | 3,890 | $0.00 | 104,096 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2025-08-01 | 3,890 | $14.30 | 100,206 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2025-08-01 | 6,110 | $0.00 | 6,110 | $0.58 |
| Common Stock | Stock Option (right to buy) | Disposition | 2025-08-01 | 3,890 | $0.00 | 3,890 | $1.68 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2028-06-13 | No | 4 | M | Direct | |
| 0 | 2029-03-13 | No | 4 | M | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on March 11, 2025, by the Reporting Person, with a plan end date of May 29, 2026.
- The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $14.14 to $14.55, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- This option is fully vested.
Billionaire Hedge Funds
